PBH Prestige Consumer Healthcare Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PBH

Price (delayed)

$58.5

Market cap

$2.91B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.65

Enterprise value

$4.22B

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio ...

Highlights
The company's debt fell by 9% YoY and by 6% QoQ
Prestige Consumer Healthcare's revenue has increased by 3.8% YoY
The quick ratio has increased by 21% YoY but it has decreased by 8% from the previous quarter
The net income has plunged by 140% YoY and by 139% from the previous quarter
The EPS has plunged by 140% YoY and by 139% from the previous quarter
Sector: Healthcare
Industry: Medical Distribution
Website: http://www.prestigebrands.com
Peers: PFE RAD JNJ PG

Key stats

What are the main financial stats of PBH
Market
Shares outstanding
49.69M
Market cap
$2.91B
Enterprise value
$4.22B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.01
Price to sales (P/S)
2.59
EV/EBIT
N/A
EV/EBITDA
297.19
EV/Sales
3.74
Earnings
Revenue
$1.13B
EBIT
-$24.75M
EBITDA
$14.19M
Free cash flow
$221.93M
Per share
EPS
-$1.65
Free cash flow per share
$4.45
Book value per share
$29.12
Revenue per share
$22.6
TBVPS
$9.71
Balance sheet
Total assets
$3.35B
Total liabilities
$1.91B
Debt
$1.37B
Equity
$1.45B
Working capital
$231.03M
Liquidity
Debt to equity
0.94
Current ratio
2.44
Quick ratio
1.4
Net debt/EBITDA
92.25
Margins
EBITDA margin
1.3%
Gross margin
55.4%
Net margin
-7.3%
Operating margin
-2%
Efficiency
Return on assets
-2.3%
Return on equity
-5.2%
Return on invested capital
-1.5%
Return on capital employed
-0.8%
Return on sales
-2.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PBH stock price

How has the Prestige Consumer Healthcare stock price performed over time
Intraday
3.17%
1 week
-0.9%
1 month
-5.23%
1 year
3.71%
YTD
-6.55%
QTD
-6.59%

Financial performance

How have Prestige Consumer Healthcare's revenue and profit performed over time
Revenue
$1.13B
Gross profit
$625.29M
Operating income
-$22.42M
Net income
-$82.31M
Gross margin
55.4%
Net margin
-7.3%
The net income has plunged by 140% YoY and by 139% from the previous quarter
The company's net margin has shrunk by 139% YoY and by 138% QoQ
PBH's operating margin has dropped by 107% since the previous quarter and by 107% year-on-year
The company's operating income has shrunk by 107% YoY and by 107% QoQ

Growth

What is Prestige Consumer Healthcare's growth rate over time

Valuation

What is Prestige Consumer Healthcare stock price valuation
P/E
N/A
P/B
2.01
P/S
2.59
EV/EBIT
N/A
EV/EBITDA
297.19
EV/Sales
3.74
The EPS has plunged by 140% YoY and by 139% from the previous quarter
PBH's price to book (P/B) is 18% higher than its 5-year quarterly average of 1.7 and 12% higher than its last 4 quarters average of 1.8
The equity has contracted by 14% from the previous quarter and by 8% YoY
The price to sales (P/S) is 18% higher than the 5-year quarterly average of 2.2
Prestige Consumer Healthcare's revenue has increased by 3.8% YoY

Efficiency

How efficient is Prestige Consumer Healthcare business performance
Prestige Consumer Healthcare's return on assets has shrunk by 141% YoY and by 140% QoQ
PBH's ROE has shrunk by 140% QoQ and by 138% YoY
Prestige Consumer Healthcare's ROIC has plunged by 108% YoY and by 108% from the previous quarter
The ROS has plunged by 107% from the previous quarter and by 107% YoY

Dividends

What is PBH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PBH.

Financial health

How did Prestige Consumer Healthcare financials performed over time
Prestige Consumer Healthcare's total assets is 76% higher than its total liabilities
The quick ratio has increased by 21% YoY but it has decreased by 8% from the previous quarter
The current ratio is up by 20% year-on-year but it has declined by 4.3% since the previous quarter
The company's debt is 6% lower than its equity
The equity has contracted by 14% from the previous quarter and by 8% YoY
Prestige Consumer Healthcare's debt to equity has increased by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.